Benitec Biopharma (BNTC) Current Leases (2020 - 2025)

Benitec Biopharma has reported Current Leases for 6 years, with the latest figure at $468000.0 in Q4 2025.

• Quarterly Current Leases changed N/A year-over-year to $468000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $468000.0 (changed N/A YoY) and the FY2025 annual result came in at $354000.0, up 24.65% from the prior year.
• Current Leases grew to $468000.0 in Q4 2025 per BNTC's latest filing, from $414000.0 in the prior quarter.
• Over five years, Current Leases peaked at $468000.0 in Q4 2025 and troughed at $194000.0 in Q3 2021.
• A 5-year average of $279578.9 and a median of $269000.0 in 2023 frame the typical range for Current Leases.
• The sharpest annual moves came in 2024 and 2025: Current Leases declined 24.64% in 2024, then surged 96.21% in 2025.
• Over 5 years, Current Leases stood at $213000.0 in 2021, then gained by 23.47% to $263000.0 in 2022, then rose by 8.75% to $286000.0 in 2023, then decreased by 26.22% to $211000.0 in 2024, then surged by 121.8% to $468000.0 in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $468000.0, $414000.0, and $354000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.